M. Baens, L. Bonsignore, R. Somers, C. Vanderheydt, S. D. Weeks et al., MALT1 auto-proteolysis is essential for NF-kappaB-dependent gene transcription in activated lymphocytes, PLoS ONE, vol.9, 2014.

N. Bide?-re, V. N. Ngo, J. Lee, C. Collins, L. Zheng et al., Casein kinase 1?? governs antigen-receptor-induced NF-??B activation and human lymphoma cell survival, Nature, vol.131, issue.7234, pp.92-96, 2009.
DOI : 10.1038/nature07613

F. Bornancin, F. Renner, R. Touil, H. Sic, Y. Kolb et al., Deficiency of MALT1 Paracaspase Activity Results in Unbalanced Regulatory and Effector T and B Cell Responses Leading to Multiorgan Inflammation, The Journal of Immunology, vol.194, issue.8, pp.3723-3734, 2015.
DOI : 10.4049/jimmunol.1402254

B. Coornaert, M. Baens, K. Heyninck, T. Bekaert, M. Haegman et al., T cell antigen receptor stimulation induces MALT1 paracaspase???mediated cleavage of the NF-??B inhibitor A20, Nature Immunology, vol.145, issue.3, pp.263-271, 2008.
DOI : 10.1038/ni1561

A. Demeyer, J. Staal, and R. Beyaert, Targeting MALT1 Proteolytic Activity in Immunity, Inflammation and Disease: Good or Bad?, Trends in Molecular Medicine, vol.22, issue.2, pp.135-150, 2016.
DOI : 10.1016/j.molmed.2015.12.004

S. M. Dubois, C. Alexia, Y. Wu, H. M. Leclair, C. Leveau et al., A catalytic-independent role for the LUBAC in NF-??B activation upon antigen receptor engagement and in lymphoma cells, Blood, vol.123, issue.14, pp.2199-2203, 2014.
DOI : 10.1182/blood-2013-05-504019

L. Elton, I. Carpentier, J. Staal, Y. Driege, M. Haegman et al., MALT1 cleaves the E3 ubiquitin ligase HOIL-1 in activated T cells, generating a dominant negative inhibitor of LUBAC-induced NF-??B signaling, FEBS Journal, vol.145, issue.3, pp.403-412, 2016.
DOI : 10.1007/s00018-015-2041-9

L. Elton, I. Carpentier, K. Verhelst, J. Staal, and R. Beyaert, The multifaceted role of the E3 ubiquitin ligase HOIL-1: beyond linear ubiquitination, Immunological Reviews, vol.4, issue.1, pp.208-221, 2015.
DOI : 10.1111/imr.12307

U. Ferch, ?. Zum-bu, C. M. Schenfelde, A. Gewies, E. Wegener et al., MALT1 directs B cell receptor???induced canonical nuclear factor-??B signaling selectively to the c-Rel subunit, Nature Immunology, vol.5, issue.9, pp.984-991, 2007.
DOI : 10.1038/nature04926

U. Ferch, B. Kloo, A. Gewies, V. Pfa?-nder, ?. Du et al., Inhibition of MALT1 protease activity is selectively toxic for activated B cell???like diffuse large B cell lymphoma cells, The Journal of Experimental Medicine, vol.6, issue.11, pp.2313-2320, 2009.
DOI : 10.1073/pnas.1732008100

L. Fontan, C. Yang, V. Kabaleeswaran, L. Volpon, M. J. Osborne et al., MALT1 Small Molecule Inhibitors Specifically Suppress ABC-DLBCL In??Vitro and In??Vivo, Cancer Cell, vol.22, issue.6, pp.812-824, 2012.
DOI : 10.1016/j.ccr.2012.11.003

B. Fu, S. Li, L. Wang, M. A. Berman, and M. E. Dorf, The ubiquitin conjugating enzyme UBE2L3 regulates TNF??-induced linear ubiquitination, Cell Research, vol.1, issue.3, pp.376-379, 2014.
DOI : 10.1093/hmg/ddq264

S. Hailfinger, G. Lenz, V. Ngo, A. Posvitz-fejfar, F. Rebeaud et al., Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma, Proc. Natl. Acad. Sci. USA, 2009.
DOI : 10.1073/pnas.0907511106

S. Hailfinger, H. Nogai, C. Pelzer, M. Jaworski, K. Cabalzar et al., Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines, Proc. Natl. Acad. Sci. USA, pp.14596-14601, 2011.

S. Hailfinger, G. Lenz, and M. Thome, Targeting B-cell lymphomas with inhibitors of the MALT1 paracaspase, Current Opinion in Chemical Biology, vol.23, pp.47-55, 2014.
DOI : 10.1016/j.cbpa.2014.09.025

K. Iwai, H. Fujita, and Y. Sasaki, Linear ubiquitin chains: NF-??B signalling, cell death and beyond, Nature Reviews Molecular Cell Biology, vol.21, issue.8, pp.503-508, 2014.
DOI : 10.1038/nrm3836

M. Jaworski, B. J. Marsland, J. Gehrig, W. Held, S. Favre et al., Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity, The EMBO Journal, vol.33, issue.23, pp.2765-2781, 2014.
DOI : 10.15252/embj.201488987

T. Klein, S. Fung, F. Renner, M. A. Blank, A. Dufour et al., The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-kappaB signalling, Nat. Commun, vol.6, issue.8777, 2015.

D. Nagel, S. Spranger, M. Vincendeau, M. Grau, S. Raffegerst et al., Pharmacologic Inhibition of MALT1 Protease by Phenothiazines as a Therapeutic Approach for the Treatment of Aggressive ABC-DLBCL, Cancer Cell, vol.22, issue.6, pp.825-837, 2012.
DOI : 10.1016/j.ccr.2012.11.002

V. N. Ngo, R. E. Davis, L. Lamy, X. Yu, H. Zhao et al., A loss-of-function RNA interference screen for molecular targets in cancer, Nature, vol.22, issue.7089, pp.106-110, 2006.
DOI : 10.1038/nature04687

F. Rebeaud, S. Hailfinger, A. Posevitz-fejfar, M. Tapernoux, R. Moser et al., The proteolytic activity of the paracaspase MALT1 is key in T cell activation, Nature Immunology, vol.17, issue.3, pp.272-281, 2008.
DOI : 10.1038/ni1568

A. L. Shaffer, Y. Iii, R. M. Staudt, and L. M. , Pathogenesis of Human B Cell Lymphomas, Annual Review of Immunology, vol.30, issue.1, pp.565-610, 2012.
DOI : 10.1146/annurev-immunol-020711-075027

J. Staal, Y. Driege, T. Bekaert, A. Demeyer, D. Muyllaert et al., T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1, The EMBO Journal, vol.2, issue.9, pp.1742-1752, 2011.
DOI : 10.1038/emboj.2011.85

M. Thome, J. E. Charton, C. Pelzer, and S. Hailfinger, Antigen Receptor Signaling to NF-??B via CARMA1, BCL10, and MALT1, Cold Spring Harbor Perspectives in Biology, vol.2, issue.9, p.3004, 2010.
DOI : 10.1101/cshperspect.a003004

F. Tokunaga, S. Sakata, Y. Saeki, Y. Satomi, T. Kirisako et al., Involvement of linear polyubiquitylation of NEMO in NF-??B activation, Nature Cell Biology, vol.177, issue.2, pp.123-132, 2009.
DOI : 10.1002/(SICI)1522-2683(20000501)21:9<1694::AID-ELPS1694>3.0.CO;2-W

Y. Yang, R. Schmitz, J. Mitala, A. Whiting, W. Xiao et al., Essential Role of the Linear Ubiquitin Chain Assembly Complex in Lymphoma Revealed by Rare Germline Polymorphisms, Cancer Discovery, vol.4, issue.4, pp.480-493, 2014.
DOI : 10.1158/2159-8290.CD-13-0915